UPDATED Feb 20, 2024
Investing in companies that think about the future will generate eco-friendly products and sustainable returns. As consumers become more environmentally-aware, demand will increase for these companies' products.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
4597Solasia Pharma K.K | JP¥37.00 | -14.0% | -27.5% | JP¥6.8b | JP¥100.00 | PS10.4x | E71.0% | n/a | ||
2395Shin Nippon Biomedical Laboratories | JP¥1,630.00 | 2.7% | -37.7% | JP¥67.9b | JP¥3,650.00 | PE12.3x | E23.2% | 3.1% | ||
4978ReproCELL | JP¥167.00 | 0% | -37.9% | JP¥14.3b | n/a | PS5.7x | E99.7% | n/a | ||
4587PeptiDream | JP¥1,556.50 | 25.2% | -14.7% | JP¥209.2b | JP¥2,716.67 | PE66.5x | E28.2% | n/a | ||
4592SanBio | JP¥679.00 | -0.1% | 0% | JP¥44.9b | JP¥1,742.00 | PB24.2x | E61.7% | n/a | ||
7774Japan Tissue Engineering | JP¥510.00 | 3.7% | 1.4% | JP¥20.4b | JP¥1,200.00 | PS8.7x | E219.4% | n/a | ||
4584Kidswell Bio | JP¥131.00 | 2.3% | -55.6% | JP¥5.0b | JP¥800.00 | n/a | E90.3% | n/a | ||
4568Daiichi Sankyo Company | JP¥4,931.00 | 3.3% | 11.6% | JP¥9.4t | JP¥5,480.00 | PE50.8x | E24.8% | 1.2% | ||
4880CellSource | JP¥1,241.00 | -1.0% | -65.1% | JP¥24.6b | JP¥2,000.00 | PE26.6x | E21.7% | 0.4% | ||
4974Takara Bio | JP¥1,051.00 | -11.8% | -39.5% | JP¥126.6b | JP¥1,866.67 | PE80.6x | E32.2% | 1.6% | ||
4503Astellas Pharma | JP¥1,677.00 | 0.7% | -11.3% | JP¥3.0t | JP¥2,329.33 | PE716.3x | E40.3% | 4.2% | ||
7079WDB coco | JP¥4,830.00 | 7.6% | -10.2% | JP¥11.6b | JP¥9,000.00 | PE15x | E11.4% | n/a | ||
4565Sosei Group | JP¥1,439.00 | 4.7% | -41.1% | JP¥123.6b | JP¥2,167.50 | PS10.1x | E46.5% | n/a | ||
4502Takeda Pharmaceutical | JP¥4,431.00 | 1.8% | 3.2% | JP¥7.0t | JP¥4,703.89 | PE39x | E22.0% | 4.2% | ||
2183Linical | JP¥447.00 | -14.9% | -35.7% | JP¥10.1b | JP¥500.00 | PE14.8x | E20.6% | 3.4% | ||
4523Eisai | JP¥6,198.00 | -5.4% | -18.3% | JP¥1.8t | JP¥8,864.29 | PE39.1x | E16.5% | 2.6% | ||
4581Taisho Pharmaceutical Holdings | JP¥8,594.00 | 0.05% | 58.9% | JP¥704.4b | JP¥6,180.00 | PE83.7x | E23.7% | 1.2% | ||
4530Hisamitsu Pharmaceutical | JP¥4,005.00 | -2.0% | 2.2% | JP¥303.4b | JP¥4,250.00 | PE21.2x | E15.0% | 2.1% | ||
4516Nippon Shinyaku | JP¥4,931.00 | -0.02% | -21.4% | JP¥332.1b | JP¥7,814.29 | PE13.8x | E11.3% | 2.5% | ||
4577Daito PharmaceuticalLtd | JP¥1,992.00 | 1.0% | -9.6% | JP¥31.2b | JP¥2,905.00 | PE9.2x | E10.3% | 3.0% | ||
4534Mochida Pharmaceutical | JP¥3,180.00 | 0.2% | -6.1% | JP¥113.0b | JP¥3,200.00 | PE37.5x | E22.5% | 2.5% | ||
4553Towa Pharmaceutical | JP¥2,999.00 | -6.1% | 56.9% | JP¥147.7b | JP¥3,410.00 | PE12.6x | E3.3% | 2.0% | ||
2160GNI Group | JP¥3,615.00 | 42.6% | 226.9% | JP¥187.2b | JP¥3,000.00 | PE22.3x | E-2.9% | n/a | ||
4593Healios K.K | JP¥124.00 | 1.6% | -67.5% | JP¥11.1b | JP¥280.00 | PS92.4x | E15.7% | n/a |